Download PDF
Dtsch Med Wochenschr 2008; 133(24): 1306
DOI: 10.1055/s-2008-1077259
Pro & Contra | Commentary
Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York

Impfung gegen Angiotensin II - pro

Immunization against angiotensin II - pro J. Nussberger1
  • 1Département de médecine interne, CHUV, Lausanne
Further Information

Publication History

Publication Date:
04 June 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Hypertonie - Angiotensin II - Impfung

Key words

hypertension - angiotensin II - vaccination

Literatur

  • 1 Ambühl P M. et al . A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.  J Hypertens. 2007;  25 63-72
    Google Scholar
  • 2 Brown M J. et al . Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects.  Clin Sci. 2004;  107 167-173
    Google Scholar
  • 3 MullerJE, Tofler G H, Stone P H. Circadian variation and triggers of onset of acute cardiovascular disease.  Circulation. 1989;  79 733-743
    Google Scholar
  • 4 Tissot A C. et al . Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.  Lancet. 2008;  371 821-827
    Google Scholar

Prof. Dr. Jürg Nussberger

CHUV-NES 6027, Department of Internal Medicine, Division of Angiology and Hypertension

CH-1011 Lausanne

Phone: ++ 4121/3140-750

Fax: ++ 4121/3140-761

Email: Juerg.Nussberger@chuv.ch

      >